Name: David H. Barad, MD, MS - Center for Human Reproduction
Name: David H. Barad, MD, MS - Center for Human Reproduction Name: David H. Barad, MD, MS - Center for Human Reproduction
Other Professional ActivitiesAd Hoc Review: RFA-AG-94-002 "Menopause and Health in Aging Women" April 12-13, 1994NHLBI Special Emphasis Panel: RFP-NHLBI-HC-94-16 & 17 "Angiographic Trial inWomen" September 26-27, 1994P&P HRT Special Interest Group – Women’s Health Initiative (1997 – present)Hormone Replacement Committee – Women’s Health Initiative (1997 – present)Hormone Trials Advisory Committee Chair – Women’s Health Initiative (2002 – present)Steering Committee – Women’s Health Initiative (2002 – present)New York State Task Force on Life and the Law – Advisory Group on ReproductiveTechnologies (1999 - 2000) Consent for ART and Donor services.Co-Chair – HRT and CaD adherence and Retention Conference – Women’s HealthInitiative (1999 - 2000)Chair – HRT – Report of interval findings in the Women’s Health Initiative toparticipants. – Women’s Health Initiative (2000)Co-Chair Women’s Health Initiative Clinical Trial – Closeout Working Group (1999 topresent)Vice-Chair ASRM Menopause Special Interest Group (2003)Advisory BoardsJournal ReviewNew York City Resolve: Medical Advisory Board, 1998-1999American Infertility Association: Medical Advisory Board, 1999- 2000Obstetrics and GynecologyAmerican Journal of Obstetrics and GynecologyFertility and SterilityEditorial BoardJournal of Assisted Reproduction and GeneticsCV David Barad Page 6
NIH Funded ResearchCo-Investigator- Women’s Health Initiative .....................................................................1994-PresentThe Clinical Center of the Department of Obstetrics, Gynecology & Women’s Health of theMontefiore Medical Center/ Albert Einstein College is one of 40 clinical centers selected to conductthe WHI Clinical Trial and Observational Study and is the only one in the metropolitan New Yorkarea. The Women’s Health Initiative (WHI) is a national, multicenter study of the health ofpostmenopausal women and consists of several overlapping clinical trials to test interventions toprevent breast cancer, heart disease and colorectal cancer and osteoporosis. The WHI also includesan observational study to uncover disease markers and risk factors. The clinical trials are initiated todetermine if hormone replacement therapy (HRT) prevents heart disease, osteoporosis and colorectalcancer. One ancillary study seeks to determine if HRT prevents Alzheimer's disease and ageassociatedcognitive decline. The Dietary Modification Trial seeks to determine if a low fat, highgrain, fruit and vegetable eating patterns will prevent breast cancer and heart disease. TheCalcium/Vitamin D supplement trial is to determine if these supplements will prevent osteoporosisand colorectal cancer. The WHI is the largest clinical trial ever funded by NIH. Nationally, 160, 000women are participating. The WHI represents a collaborative effort of the departments ofEpidemiology and Social Medicine, OBGYN-WH, and Medicine. The AECOM/ MMC ClinicalCenter succeeded in recruiting the goal of 4,500 community-based women within the Bronx and NYMetropolitan area.CV David Barad Page 7
- Page 1: CURRICULUM VITAEName:David H. Barad
- Page 4 and 5: Hospital AppointmentsInstitution Ad
- Page 8 and 9: Invited Non-AECOM presentations ove
- Page 10 and 11: 13. Borgatta, L., L. Gruss, D. Bara
- Page 12 and 13: 41. Anderson, G.L., H.L. Judd, A.M.
- Page 15 and 16: 24-27, 1982; Dallas, Tx; 1982.3. Ba
- Page 17 and 18: 28. Barad D, Feinman M. A compariso
- Page 19 and 20: Predictive Value of Single Versus M
- Page 21: BiographyDr. Barad an Associate Cli
NIH Funded ResearchCo-Investigator- Women’s Health Initiative .....................................................................1994-PresentThe Clinical <strong>Center</strong> of the Department of Obstetrics, Gynecology & Women’s Health of theMontefiore Medical <strong>Center</strong>/ Albert Einstein College is one of 40 clinical centers selected to conductthe WHI Clinical Trial and Observational Study and is the only one in the metropolitan New Yorkarea. The Women’s Health Initiative (WHI) is a national, multicenter study of the health ofpostmenopausal women and consists of several overlapping clinical trials to test interventions toprevent breast cancer, heart disease and colorectal cancer and osteoporosis. The WHI also includesan observational study to uncover disease markers and risk factors. The clinical trials are initiated todetermine if hormone replacement therapy (HRT) prevents heart disease, osteoporosis and colorectalcancer. One ancillary study seeks to determine if HRT prevents Alzheimer's disease and ageassociatedcognitive decline. The Dietary Modification Trial seeks to determine if a low fat, highgrain, fruit and vegetable eating patterns will prevent breast cancer and heart disease. TheCalcium/Vitamin D supplement trial is to determine if these supplements will prevent osteoporosisand colorectal cancer. The WHI is the largest clinical trial ever funded by NIH. Nationally, 160, 000women are participating. The WHI represents a collaborative ef<strong>for</strong>t of the departments ofEpidemiology and Social Medicine, OBGYN-WH, and Medicine. The AECOM/ MMC Clinical<strong>Center</strong> succeeded in recruiting the goal of 4,500 community-based women within the Bronx and NYMetropolitan area.CV <strong>David</strong> <strong>Barad</strong> Page 7
Change language